$TVRD Cashflow Statement | Understand Stock

$TVRD

$0.87 +$0.02 (2.76%) Close

$TVRD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
Noncash lease expense
Stock-based compensation expense
Non-cash interest expense on liability related to sales of future royalties and milestones, net of issuance costs accretion
Impairment of long-lived assets
Inventory write-down
Change in fair value of Convertible Notes
Non-cash lease expense
Accretion of net discounts on short-term investments
Realized gain on sale of available-for-sale marketable securities
Realized gain on sale of property and equipment
Interest accrued on Convertible Notes
Changes in operating assets and liabilities:
Accounts receivable, net - related party
Inventory
Income tax receivable
Other receivables
Prepaid expenses
Prepaid expenses and other assets
Accounts payable and accrued expenses
Operating lease liabilities
Reimbursement of lease incentive
Other

Net cash used in operating activities
Cash flows from investing activities:
Proceeds from maturities of available-for-sale marketable securities
Proceeds from redemptions of available-for-sale marketable securities, at par
Proceeds from sale of available-for-sale marketable securities
Purchases of available-for-sale marketable securities
Purchases of property and equipment
Proceeds from sale of property and equipment
Purchases of short-term investments
Maturities of short-term investments
Net cash used in investing activities

Cash flows from financing activities:
Payments to royalty purchase and sale agreement
Proceeds from royalty purchase and sale agreement, net of $1.0 million of issuance costs
Net proceeds from sales of common stock under open market sales agreement
Cash acquired in connection with the Merger
Payments for Merger transaction costs
Proceeds from Convertible Notes
Proceeds from exercise of stock options
Proceeds from the sale of common stock under license agreement with Vifor International
Net cash provided by financing activities

Net (decrease) increase in cash, cash equivalents and restricted cash
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents - beginning of year
Cash and cash equivalents - end of year
Non-cash investing and financing activities
Receivable for additional HCR financing earned
Incremental right-of-use asset in exchange for non-cash lease liability from modification of lease
Transfer of property and equipment per lease assignment
Initial direct costs included as right-of-use asset from modification of lease
Accrual for leasehold improvements
Merger transaction costs included in accounts payable and accrued expenses
Conversion of redeemable convertible preferred stock to common stock
Conversion of Convertible Notes to common stock

Comments